Viral diseases, especially those caused by mixed infections, are among the economically most important diseases of sweetpotato. The difficulties inherent in detecting, quantifying, and isolating viruses directly from sweetpotato have impeded progress in sweetpotato virus research. Real-time polymerase chain reaction (PCR) assays were developed for the detection and relative quantification in singleplex reactions of the potyviruses Sweet potato feathery mottle virus (SPFMV), Sweet potato virus G (SPVG), and Ipomoea vein mosaic virus (IVMV); the crinivirus Sweet potato chlorotic stunt virus (SPCSV); and the begomovirus Sweet potato leaf curl virus(SPLCV) directly from infected sweetpotato plants. There was no significant effect from potential inhibitors in total nucleic acid extracts from sweetpotato leaves on the performance of the real-time PCR assays. Virus titers of SPFMV, IVMV, and SPVG were quantified using real-time PCR and found to be lower in singly infected sweetpotato plants compared with singly infected Brazilian morning-glory (Ipomoea setosa Ker.) and I. nil cv. Scarlet O'Hara plants. Real-time PCR was a more efficient detection method for SPLCV than conventional PCR assay.
Sweet potato virus disease (SPVD) is the most serious viral disease of sweetpotato globally. This disease is caused by the synergistic interaction between the aphid-transmitted potyvirus Sweet potato feathery mottle virus (SPFMV) and the whitefly-transmitted crinivirus Sweet potato chlorotic stunt virus (SPCSV). In sweetpotato, titers of SPFMV have been shown to be significantly enhanced when coinfecting with SPCSV. In this study, the effect of SPCSV on titers of different potyviruses and potyvirus strains infecting sweetpotato in the United States was investigated using real-time quantitative reverse transcription-polymerase chain reaction (RT-PCR). No significant difference was observed in titers of the russet crack strain of SPFMV (SPFMV-RC), Ipomoea vein mosaic virus (IVMV), and Sweet potato virus G (SPVG) between single and mixed infections. Titers of all potyviruses and potyvirus strains evaluated were enhanced in the presence of SPCSV, suggesting that a conserved mechanism may underlie these interactions. Titers of the common strain of SPFMV (SPFMV-C), which did not cause SPVD-like symptoms when coinfecting with SPCSV, were also significantly enhanced in the presence of SPCSV. Furthermore, titers of SPCSV were found to be lower in treatments involving pairwise infections compared with plants infected by SPCSV alone. The degree of potyvirus titer enhancement did not correspond to the severity of symptoms observed in certain treatments involving pairwise infections.
Sweet potato virus disease (SPVD) is the most devastating disease of sweetpotato [Ipomoea batatas (L.) Lam.] globally. It is caused by the co-infection of plants with a potyvirus, sweet potato feathery mottle virus (SPFMV), and a crinivirus, sweet potato chlorotic stunt virus (SPCSV). In this study we report the use of cDNA microarrays, containing 2765 features from sweetpotato leaf and storage root libraries, in an effort to assess the effect of this disease and its individual viral components on the gene expression profile of I. batatas cv. Beauregard. Expression analysis revealed that the number of differentially expressed genes (P < 0.05) in plants infected with SPFMV alone and SPCSV alone compared to virus-tested (VT) plants was only 3 and 14, respectively. However, these findings are in contrast with SPVD-affected plants where more than 200 genes were found to be differentially expressed. SPVD-responsive genes are involved in a variety of cellular processes including several that were identified as pathogenesis- or stress-induced.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.